Abstract:ABSTRACT Gut dysbiosis is closely related to dysregulated microRNAs (miRNAs) in the intestinal epithelial cells, which plays an important role in the pathogenesis of Crohn’s disease (CD). We investigated the relationship between fecal gut microbiome (GM) and intestinal tissue miRNAs in different stages of pediatric CD. Metagenomic analysis and miRNA sequencing were conducted to examine the GM and intestinal miRNA profiles of CD patients before and after clinical induction therapy and the controls. Twenty-seven newly diagnosed, therapy-naïve pediatric patients with active CD and 11 non-inflammatory bowel disease (IBD) controls were recruited in this study. Among CD patients, 11 patients completed induction treatment and reached clinical remission. Both GM and miRNA profiles were significantly changed between CD patients and controls. Seven key bacteria were identified at species level including Defluviitalea raffinosedens , Thermotalea metallivorans , Roseburia intestinalis , Dorea sp. AGR2135, Escherichia coli , Shigella sonnei , and Salmonella enterica , the exact proportions of which were further validated by real-time quantitative PCR analysis. Eight key miRNAs were also identified including hsa-miR-215-5p, hsa-miR-194-5p, hsa-miR-12135, hsa-miR-509-3-5p, hsa-miR-212-5p, hsa-miR-4448, hsa-miR-501-3p, and hsa-miR-503-5p. The functional enrichment analysis of differential miRNAs indicated the significantly altered cyclin protein, cyclin-dependent protein, and cell cycle pathway. The close interactions between seven key bacteria and eight key miRNAs were further investigated by miRNA target prediction. The association between specific miRNA expressions and key gut bacteria at different stages of CD supported their important roles as potential molecular biomarkers. Understanding the relationship between them will help us to explore the molecular mechanisms of CD. IMPORTANCE Since previous studies have focused on the change of the fecal gut microbiome and intestinal tissue miRNA in pediatric Crohn’s disease (CD), the relationship between them in different stages is still not clear. This is the first study to explore the gut microbiota and miRNA and their correlations with the Pediatric Crohn’s Disease Activity Index (PCDAI). Crohn’s Disease Endoscopic Index of Severity (CDEIS), and calprotectin, by applying two omics approach in three different groups (active CD, CD in remission with exclusive enteral nutrition or infliximab induction therapy, and the healthy controls). Both gut microbiome structure and the miRNA profiles were significantly changed in the different stage of CD. Seven key gut microbiome at species and eight key miRNAs were found, and their close interactions were further fully investigated by miRNA target prediction.

Intestinal Dysbiosis in Pediatric Crohn's Disease Patients with IL10RA Mutations

Association of Polymorphisms in the IL‐10 Promoter Region with Crohn's Disease

Gut Microbiota in Children with Juvenile Idiopathic Arthritis: Characteristics, Biomarker Identification, and Usefulness in Clinical Prediction.

Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease

Characteristics of the gut microbiota and the effect of Bifidobacterium in very early-onset inflammatory bowel disease patients with IL10RA mutations

Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature

Comprehensive Mutation Screening for 10 Genes in Chinese Patients Suffering Very Early Onset Inflammatory Bowel Disease

Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.

Characterization of Specific Signatures of the Oral Cavity, Sputum, and Ileum Microbiota in Patients With Crohn's Disease

Molecular-Phylogenetic Characterization of the Microbiota in Ulcerated and Non-Ulcerated Regions in the Patients with Crohn's Disease

The absence of interleukin 10 affects the morphology, differentiation, granule content and the production of cryptidin-4 in Paneth cells in mice

Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review

Phenotypic Characterization Of Very Early-Onset Inflammatory Bowel Disease With Interleukin-10 Signaling Deficiency: Based On A Large Cohort Study

Characterization of Fungal and Bacterial Dysbiosis in Young Adult Chinese Patients with Crohn's Disease.

Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.

Exploring the intestinal ecosystem: from gut microbiota to associations with subtypes of inflammatory bowel disease

Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome

Enhanced Microbiota Profiling in Patients with Quiescent Crohn's Disease Through Comparison with Paired Healthy First-Degree Relatives.

Fecal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease Patients with Irritable Bowel Syndrome-Type Symptoms

Fecal Microbial Signatures Are Associated with Engraftment Failure Following Umbilical Cord Blood Transplantation in Pediatric Crohn's Disease Patients with IL10RA Deficiency.

Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease